WuXi Biologics posts 4.3% rise in first-half profit, defying biotech headwinds
- Posted on August 25, 2026
- By South China Morning Post
- 2 Views
- 1 min read
In brief
Generating AI summary…
WuXi Biologics posts 4.3% rise in first-half profit, defying biotech headwinds
Higher gross margins, surging projects and continued demand from North American markets help power the drug developer’s strong first-half performance.
)